Score the patch / OTA update mechanism your device ships with against integrity, transport, deployment safety, lifecycle, and - for AI/ML devices - PCCP-bound model update and rollback expectations under §524B and the FDA's Feb 3, 2026 final premarket cybersecurity guidance.
Reviewed by
Christian Espinosa
Founder & CEO, Blue Goat Cyber
Update Integrity & Authenticity
What stops a malicious or corrupted update from reaching the device.
Update images are signed with a manufacturer-controlled key
criticalAsymmetric signature, not just a checksum.
Device verifies signature before applying any update
criticalBootloader / OS verifies before commit.
Signing chain anchored in hardware or measured boot
highRoot key in HSM / secure element / TPM.
Signing keys live in an HSM with documented access controls
highNo keys on engineer laptops.
Update Transport & Distribution
How updates get from your build system to the device.
Update server uses mutual TLS or pinned certificates
highServer authenticates the device and vice versa.
Rollback protection (anti-downgrade) is enforced
highMonotonic version counter checked at boot.
Delta or differential updates use the same signing + verification path
mediumDeltas are a common bypass.
Update Deployment & Safety
How updates get applied without harming patients.
A/B (dual-bank) update with automatic rollback on boot failure
criticalDevice never bricks on a bad update.
Update preconditions checked (not in clinical use, battery, network)
highNo updates mid-procedure.
Operator / customer notification and consent workflow exists
mediumPer labeling requirements.
Staged / canary rollout supported
mediumCatch field-only issues before fleet-wide.
Lifecycle & Reporting
Postmarket controls reviewers expect under §524B.
Documented SLAs for critical / KEV-relevant patch deployment
highAligned to Postmarket Cadence Calculator output.
Per-device update success / failure telemetry collected
highYou can prove fleet status to reviewers.
Audit log of every update (who, what, when, version, signature)
mediumTamper-evident.
Key compromise / revocation playbook exists and has been rehearsed
highIncluding emergency re-signing.
Cyber update support window stated in labeling (with EoS date)
mediumPer §524B and FDA premarket guidance.
AI / PCCP Model Updates
For AI/ML-enabled devices: how model weight updates ship, stay bound to the authorized PCCP envelope, and roll back safely. Skip this group only if the device ships no learned model.
Model weights ship over a separate, identified update channel (distinct from firmware / OS)
highReviewers want to see model artifacts treated as a first-class update class, not bundled silently with firmware.
Model artifacts (weights + preprocessing + thresholds) are signed and verified before load
criticalCover the full inference bundle, not just the .pt / .onnx file.
Each model update is checked against the authorized PCCP envelope on-device before activation
criticalArchitecture family, input modality, intended use, performance floors, and population are all inside the cleared modification protocol.
Model manifest cryptographically binds weights hash to the PCCP submission ID and protocol version
highSo a model can be traced back to the exact PCCP version the FDA cleared.
Out-of-envelope model changes are blocked at deploy time and require a new submission path
criticalNo silent re-architecture under the same clearance.
Previous validated model version is retained on-device and can be reactivated automatically
criticalA/B for model weights, not just firmware.
Model rollback is bounded by a known-good allow-list (no downgrade to vulnerable / withdrawn weights)
highAnti-downgrade for models, with an explicit exception for safety rollback.
Post-update real-world performance monitoring gates the rollout and can trigger automatic rollback
highDrift, subgroup performance, and confidence calibration tracked per release.
Per-device log records active model version, manifest hash, PCCP version, and activation time
mediumTamper-evident provenance for postmarket investigations.
What you'll see after you submit
Common misconceptions
Myth: TLS to the update server is enough.
Reality: TLS protects the channel. The FDA expects signature verification of the image itself, plus rollback protection - bytes on the device must be authenticated, not just the transport.
Myth: We don't need A/B partitions because we test thoroughly.
Reality: Field environments differ from labs. Without dual-bank + watchdog rollback, one bad release can brick a fleet and turn a security update into a recall.
Myth: Signing keys can live on the build server.
Reality: Keys on a build server are one CI compromise away from being used to push a malicious update at scale. HSM / KMS with dual-control is the bar reviewers expect.
References & further reading
Tracked signals that change what reviewers expect. Items move on as new ones land.
RHEL 7 Extended Life Support phase ends - devices on RHEL 7 need a compensating-controls memo
AI-letter analysis - 62% of FDA cyber deficiencies cite a missing or stale CVD URL
AAMI TIR97:2019 errata published - clarifies postmarket triage SLAs
Define the authorized model-change envelope this questionnaire enforces on-device.
Read PCCP BuilderPatch SLAs that go with your update mechanism.
Read Postmarket Cadence CalculatorDecide when to ship an emergency patch vs schedule.
Read Controlled vs Uncontrolled Risk ClassifierRun vulnerability response with the right SLAs in place.
Read Postmarket cybersecurity services